Rewriting Life

Mapping a Stem Cell Policy

European countries are imposing a patchwork of tough restrictions that are impeding research.

Embryonic stem cells, with their unique power to differentiate into every type of cell in the human body, have been hailed as the source of possible cures for everything from heart disease to Parkinson’s but reviled by antiabortion activists, who oppose harvesting the cells from surplus frozen embryos. When the U.S. government decided in 2001 to deny funding for research that uses embryonic cells derived after August 9, 2001, observers predicted a brain drain of U.S. researchers to Europe.

But European countries are adopting their own restrictions, in some cases tougher than those in the U.S. The resulting patchwork-combined with low biotechnology funding-has hamstrung European embryonic-stem-cell research, says Martyn Postle, director of Cambridge Healthcare and Biotech, a consultancy in Cambridge, England. Worse, he adds, is legislation in the European Parliament-the lawmaking body of the European Union (which includes most European countries; nonmembers include Norway, Switzerland, and Iceland) that could outlaw all embryonic-stem-cell research in the EU. Such a ban would have to be enforced separately in each country. In short, the European research climate is not universally favorable.

Uh oh–you've read all of your free articles for this month.

Insider Premium
$179.95/yr US PRICE

More from Rewriting Life

Reprogramming our bodies to make us healthier.

Want more award-winning journalism? Subscribe to Insider Basic.
  • Insider Basic {! insider.prices.basic !}*

    {! insider.display.menuOptionsLabel !}

    Six issues of our award winning magazine and daily delivery of The Download, our newsletter of what’s important in technology and innovation.

    See details+

    What's Included

    Bimonthly home delivery and unlimited 24/7 access to MIT Technology Review’s website.

    The Download. Our daily newsletter of what's important in technology and innovation.

/
You've read all of your free articles this month. This is your last free article this month. You've read of free articles this month. or  for unlimited online access.